|
⚲
|
| Keyboard |
| McClung David Mark
✚
|
|
|---|---|
| CIK # | 0001811505 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001811505] | |
| 4 | [0001811505] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McClung David Mark | |
| Sangamo Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2023-11-25 | Tax withheld | 1,925 | $0.38 | 732 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2023-08-25 | Tax withheld | 1,925 | $0.77 | 1,482 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2023-06-25 | Tax withheld | 11,528 | $1.19 | 13,718 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2023-05-25 | Tax withheld | 1,925 | $1.33 | 2,560 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2023-02-25 | Tax withheld | 9,745 | $2.66 | 25,922 |
|
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
|
2023-02-24 | Grant | 262,500 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2023-02-24 | Grant | 56,250 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2022-06-25 | Tax withheld | 11,525 | $4.31 | 49,673 |
|
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
|
2022-02-25 | Grant | 160,380 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2022-02-25 | Grant | 59,400 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2022-02-25 | Tax withheld | 4,610 | $5.90 | 27,199 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2021-06-25 | Tax withheld | 11,525 | $12.02 | 138,530 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2021-02-25 | Grant | 40,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
|
2021-02-25 | Grant | 80,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
|
2020-06-25 | Grant | 200,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2020-06-25 | Grant | 100,000 | $0.00 |